Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection

Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection

Introduction: Clostridium difficile is the leading cause of hospital-acquired diarrhoea. There is no defined protocol for treating severe Clostridium difficile infection (CDI) refractory to vancomycin or vancomycin and metronidazole combination therapy. The aim of this study was to evaluate the rate...

Full description

Saved in:
Bibliographic Details
Main Authors: Natasa Popovic, Milos Korac, Zorica Nesic, Branko Milosevic, Aleksandar Urosevic, Djordje Jevtovic, Mijomir Pelemis, Dragan Delic, Milica Prostran, Ivana Milosevic
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2015-10-01
Series:Journal of Infection in Developing Countries
Subjects:
oral teicoplanin
Clostridium difficile
refractory pseudomembranous colitis
recurrence
Online Access:https://jidc.org/index.php/journal/article/view/6335
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items